IN2014DN06573A - - Google Patents

Info

Publication number
IN2014DN06573A
IN2014DN06573A IN6573DEN2014A IN2014DN06573A IN 2014DN06573 A IN2014DN06573 A IN 2014DN06573A IN 6573DEN2014 A IN6573DEN2014 A IN 6573DEN2014A IN 2014DN06573 A IN2014DN06573 A IN 2014DN06573A
Authority
IN
India
Prior art keywords
modafinil
fluid
pharmaceutical composition
substrate
solubilizing
Prior art date
Application number
Other languages
English (en)
Inventor
Christophe Lebon
Pascal Suplie
Fabrice Leboeuf
Jennifer Jung
Frantz Deschamps
Original Assignee
Debregeas Et Associes Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debregeas Et Associes Pharma filed Critical Debregeas Et Associes Pharma
Publication of IN2014DN06573A publication Critical patent/IN2014DN06573A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Closures For Containers (AREA)
IN6573DEN2014 2012-02-28 2013-02-25 IN2014DN06573A (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1200580A FR2987266B1 (fr) 2012-02-28 2012-02-28 Procede d'obtention d'une composition pharmaceutique a base de modafinil, composition pharmaceutique ainsi obtenue et son application
PCT/FR2013/000051 WO2013128087A1 (fr) 2012-02-28 2013-02-25 Procédé d'obtention d'une composition pharmaceutique à base de modafinil, composition pharmaceutique ainsi obtenue et son application

Publications (1)

Publication Number Publication Date
IN2014DN06573A true IN2014DN06573A (el) 2015-06-26

Family

ID=48083446

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6573DEN2014 IN2014DN06573A (el) 2012-02-28 2013-02-25

Country Status (32)

Country Link
US (1) US9782367B2 (el)
EP (1) EP2819654B1 (el)
JP (1) JP6026566B2 (el)
KR (1) KR101911989B1 (el)
CN (1) CN104168889B (el)
AR (1) AR090168A1 (el)
AU (1) AU2013224830B2 (el)
CA (1) CA2863042A1 (el)
CL (1) CL2014002202A1 (el)
CY (1) CY1117049T1 (el)
DK (1) DK2819654T3 (el)
EA (1) EA024459B1 (el)
ES (1) ES2554794T3 (el)
FR (1) FR2987266B1 (el)
HK (1) HK1198931A1 (el)
HR (1) HRP20151280T1 (el)
HU (1) HUE027141T2 (el)
IL (1) IL234008A (el)
IN (1) IN2014DN06573A (el)
MA (1) MA37284B1 (el)
MX (1) MX349970B (el)
NZ (1) NZ628007A (el)
PH (1) PH12014501838A1 (el)
PL (1) PL2819654T3 (el)
PT (1) PT2819654E (el)
RS (1) RS54435B1 (el)
SG (1) SG11201404812QA (el)
SI (1) SI2819654T1 (el)
SM (1) SMT201600029B (el)
TW (1) TWI543779B (el)
UA (1) UA113539C2 (el)
WO (1) WO2013128087A1 (el)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
CN1249932A (zh) * 1999-09-29 2000-04-12 付俊昌 一种莫达芬尼及其光学对映体l及d异构体的新用途
JP2003525895A (ja) * 2000-03-09 2003-09-02 アストラゼネカ・アクチエボラーグ 固形分散剤の製造方法
US6489363B2 (en) 2000-10-11 2002-12-03 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
US6919378B2 (en) 2000-10-11 2005-07-19 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
US7297346B2 (en) 2001-05-25 2007-11-20 Cephalon Inc. Pharmaceutical formulations of modafinil
US20040048931A1 (en) 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US20040121003A1 (en) 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
US20060024370A1 (en) * 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
GB0523653D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
CN105233349B (zh) * 2005-07-15 2019-06-18 胶束技术股份有限公司 包含受控形态的药物粉末的聚合物涂层
CA2614777C (en) * 2005-07-21 2012-04-17 Neurohealing Pharmaceuticals, Inc. Rapid onset and short term modafinil compositions and methods of use thereof
EP2043623A4 (en) * 2006-07-12 2013-03-20 Elan Pharma Int Ltd NANOPARTICLE FORMULATIONS OF MODAFINIL
US8173169B2 (en) * 2007-07-11 2012-05-08 Hikma Pharmaceuticals Formulation and process for the preparation of modafinil
FR2943543B1 (fr) 2009-03-31 2013-02-08 Separex Sa Procede de preparation de compositions pharmaceutiques comprenant des particules fines de substance active.
KR100924236B1 (ko) * 2009-06-23 2009-10-29 충남대학교산학협력단 균일한 입도분포를 가지는 초미세입자의 신규한 제조방법 및 장치

Also Published As

Publication number Publication date
HRP20151280T1 (hr) 2016-01-01
AU2013224830A1 (en) 2014-08-21
MX2014010236A (es) 2015-04-09
EA024459B1 (ru) 2016-09-30
EP2819654A1 (fr) 2015-01-07
HUE027141T2 (hu) 2016-08-29
CL2014002202A1 (es) 2015-03-13
MX349970B (es) 2017-08-23
KR101911989B1 (ko) 2018-10-25
CN104168889B (zh) 2016-10-26
TW201340995A (zh) 2013-10-16
EP2819654B1 (fr) 2015-09-09
AR090168A1 (es) 2014-10-22
ES2554794T3 (es) 2015-12-23
PH12014501838B1 (en) 2014-11-10
JP2015508804A (ja) 2015-03-23
CN104168889A (zh) 2014-11-26
US9782367B2 (en) 2017-10-10
SMT201600029B (it) 2016-02-25
FR2987266B1 (fr) 2014-12-19
HK1198931A1 (en) 2015-06-19
SG11201404812QA (en) 2014-10-30
PH12014501838A1 (en) 2014-11-10
JP6026566B2 (ja) 2016-11-16
FR2987266A1 (fr) 2013-08-30
DK2819654T3 (en) 2015-12-21
UA113539C2 (xx) 2017-02-10
MA37284B1 (fr) 2016-06-30
CA2863042A1 (fr) 2013-09-06
IL234008A (en) 2017-02-28
US20150105470A1 (en) 2015-04-16
CY1117049T1 (el) 2017-04-05
AU2013224830B2 (en) 2017-02-02
MA20150242A2 (fr) 2015-07-31
WO2013128087A1 (fr) 2013-09-06
PT2819654E (pt) 2015-12-21
EA201400962A1 (ru) 2014-12-30
NZ628007A (en) 2015-07-31
TWI543779B (zh) 2016-08-01
KR20140129035A (ko) 2014-11-06
IL234008A0 (en) 2014-09-30
PL2819654T3 (pl) 2016-02-29
SI2819654T1 (sl) 2015-12-31
RS54435B1 (en) 2016-06-30

Similar Documents

Publication Publication Date Title
CL2013003372A1 (es) Compuestos derivados de espiro-[1,3]-oxacinas y espiro-[1,4]-oxacepinas, inhibidores de bace1 y/o bace2; composicion farmaceutica; procedimiento para prepararlos; y su uso en el tratamiento y/o la profilaxis de la enfermedad de alzheimer y diabetes.
MX365294B (es) Inhibidores de proteína cinasa dependiente de adn.
RS61767B1 (sr) 4'-fluor-nukleozidi, 4'-fluor-nukleotidi i njihovi analozi za lečenje hcv
CL2014001838A1 (es) Compuestos derivados de fluormetil-5,6-dihidro-4h-[1,3]oxazin-2-ilamina, como inhibidores de la bace1; su proceso de obtencion; composicion farmaceutica que los contiene; y su uso para el tratamiento terapeutico y/o profilactico de la enfermedad de alzheimer, esclerosis lateral amiotrofica, cancer, enfermedades cardiovasculares y enfermedades gastrointestinales, entre otras.
PL3142785T3 (pl) Sposób wytwarzania alkenoli i ich zastosowanie do wytwarzania 1,3- butadienu
MX2014005440A (es) Inhibidores de nicotinamida adenina dinucleotido difosfato oxidasa-4 y uso de los mismos.
EP2699584A4 (en) CYCLIC PEPTIDE FROM NONOMURAEA SP., METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF MICRO-BACTERIA-INFLAMMATED DISEASES THEREWITH
GB201304564D0 (en) Novel removable clothing
IN2013MU03583A (el)
MA39710A (fr) Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
IN2014MN02236A (el)
CL2014003607A1 (es) Compuestos derivados de benzodioxol, inhibidores de la acetilcolinesterasa; metodo de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o el tratamiento de la enfermedad de alzheimer.
EP2519244A4 (en) EXTRACT FROM THE CHINESE VEGETABLE TREE OF SUPERCRITIC FLUIDS FOR THE TREATMENT OF DIABETES AND METABOLISM DISEASES AND METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF
EP2964750A4 (en) METHOD AND COMPOSITIONS FOR TREATING AND / OR PREVENTING TYPE-1 DIABETES
CL2015001391A1 (es) Compuestos derivados de hidantoina, análogo de pth; composicion farmaceutica; metodo para la prevencion o el tratamieno de osteoporosis,fracturas, hipocondroplasia; y su uso para la produccion de un agente movilizador de celulas madre o un agente para prevenir o tratar osteoporosis, entre otras
MX2014014751A (es) Compuestos de heteroarilo y metodos de uso de los mismos.
MY186523A (en) Macrocyclic rip2 kinase inhibitors
MX2016008968A (es) Compuestos organicos.
WO2014197536A3 (en) Novel beta lactams as modulators of glutamate uptake and methods for use thereof
IN2014DN06573A (el)
HK1246271A1 (zh) 用於合成羥基-三甘油酯的方法及其用於預防和治療疾病的用途
MX2016013588A (es) Complejo de tanato de sitagliptina.
WO2013038200A3 (en) Neurodevelopmental disorders
HRP20161165T1 (hr) Modafinil za uporabu u liječenju ovisnosti o kokainu
IL248428B (en) 3,1-propanedisulfonic acid or its pharmaceutically acceptable salt for use in the treatment of sarcoidosis